Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[The amiodarone lung].

G Akoun, B Milleron, C Mayaud

    Revue De Pneumologie Clinique
    |January 1, 1984
    PubMed
    Summary
    This summary is machine-generated.

    Pulmonary lesions linked to amiodarone (an anti-arrhythmic drug) may indicate hypersensitivity pneumonia. Long-term amiodarone use necessitates regular respiratory monitoring to detect potential adverse effects.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    [Recommendations of French specialists on screening for lung cancer].

    Revue des maladies respiratoires·2021
    Same author

    Potential lung cancer screening outcomes using different age and smoking thresholds in the ANRS-CO4 French Hospital Database on HIV cohort.

    HIV medicine·2019
    Same author

    [IoNESCO trial: Immune neoajuvant therapy in early stage non-small cell lung cancer].

    Revue des maladies respiratoires·2018
    Same author

    [Structuring the French thoracic oncology over the last 20 years].

    Revue des maladies respiratoires·2017
    Same author

    [Current knowledge on perioperative treatments of non-small cell lung carcinomas].

    Revue des maladies respiratoires·2017
    Same author

    Pazopanib or placebo in completely resected stage I NSCLC patients: results of the phase II IFCT-0703 trial.

    Annals of oncology : official journal of the European Society for Medical Oncology·2017
    Same journal

    [Respiratory Medicine and Research: The new SPLF's anglophone journal].

    Revue de pneumologie clinique·2018
    Same journal

    [Medical journals publication: Let's change].

    Revue de pneumologie clinique·2018
    Same journal

    [Multiple ulcerated tracheobronchial mucosal lesions in the eosinophilic granulomatosis with polyangiitis].

    Revue de pneumologie clinique·2018
    Same journal

    [Medium and long-term respiratory outcome in patients operated from congenital diaphragmatic hernia: From a series of 56 patients].

    Revue de pneumologie clinique·2018
    Same journal

    [Sporadic lymphangioleiomyomatosis: A rare cause of bilateral spontaneous pneumothorax in young woman].

    Revue de pneumologie clinique·2018
    Same journal

    [COPD and smoking cessation: Patients' expectations and responses of health professionals].

    Revue de pneumologie clinique·2018
    See all related articles

    Area of Science:

    • Pulmonology
    • Pharmacology
    • Toxicology

    Context:

    • Amiodarone is a widely used anti-arrhythmic and anti-angina medication.
    • Pulmonary complications associated with amiodarone have been increasingly reported.
    • The exact mechanism of amiodarone-induced lung injury remains under investigation.

    Purpose:

    • To review and synthesize reported cases of pulmonary lesions associated with amiodarone use.
    • To explore the clinical, radiological, and pathological features of amiodarone-induced pulmonary toxicity.
    • To assess the potential mechanisms, including hypersensitivity and direct toxicity, underlying these pulmonary reactions.

    Summary:

    • Fifty-one cases of pulmonary lesions linked to amiodarone were identified across 17 publications over three years.

    Related Experiment Videos

  • Clinical and diagnostic findings suggest hypersensitivity pneumonia, though histopathology is not fully defined, with evidence supporting both toxic and immune-mediated reactions.
  • Eleven deaths were reported, with five potentially drug-related, highlighting the severity of amiodarone pulmonary toxicity.

    • Impact:

    • Highlights the risk of amiodarone-induced pulmonary lesions, potentially including hypersensitivity pneumonia and fibrosis.
    • Underscores the need for vigilant respiratory monitoring in patients on long-term amiodarone therapy.
    • Informs clinical practice regarding the potential adverse effects of amiodarone on the respiratory system.